|
FAM82B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.73256980878978E-13 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.075700E-02 |
| Stage1-vs-Stage3 |
3.146200E-01 |
| Stage1-vs-Stage4 |
2.34000000000067E-05 |
| Stage2-vs-Stage3 |
7.520800E-03 |
| Stage2-vs-Stage4 |
3.94850000000613E-05 |
| Stage3-vs-Stage4 |
7.518900E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.92543766988729E-12 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
4.699400E-01 |
| Caucasian-vs-Asian |
5.485200E-01 |
| AfricanAmerican-vs-Asian |
3.277800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.757600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.15500000008595E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.062400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.561600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.702800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.950200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.833400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.671800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.17139999999905E-05 |
| Classical-VS-Follicular |
2.22849999998997E-05 |
| Classical-VS-Other |
1.494820E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.85889970083508E-10 |
| Tall-VS-Other |
9.055800E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
1.165550E-02 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
1.68670000189053E-09 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62436730732907E-12 |
| N0-vs-N1 |
2.23779999999341E-05 |
|
|
